UROMITEXAN sol inj 400 mg/4ml 15 amp 4 ml

7680434070317 CH-43407 V03AF01 05.99.0.

Reimbursement limitations:

UROMITEXAN

Seulement en combinaison de cytostatiques.

UROMITEXAN sol inj 400 mg/4ml 15 amp 4 ml
UROMITEXAN sol inj 400 mg/4ml 15 amp 4 ml
UROMITEXAN sol inj 400 mg/4ml 15 amp 4 ml
1 / 3
google

Details

Product number
4340702
CPT
-
Packaging group
15
Unit
Ampulle(n)
Composition
mesnum 400 mg, dinatrii edetas, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 4 ml corresp. natrium 56.6 - 59.35 mg.

Articles (1)

Uromitexan, Injektions-/Infusionslösung
Ampullen
15
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
15/11/2023
Professional SmPC
Français
15/11/2023
Professional SmPC
Italien
15/11/2023

Detailed composition

Substance Quantity Type Category
(N/A)
400.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 78.90
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1982

Authorization holder

Baxter AG

8152 Opfikon

Authorization information

Swissmedic authorization number
43407
Drug name
Uromitexan, Injektions-/Infusionslösung
Galenic form
LSIN
ATC Code
V03AF01
Authorization status
Z
Dispensation category
B
First authorization
31/03/1981
Authorization expiration date
31/12/9999
IT number
05.99.0.
Domain
Human medicine
Field of application
Verhütung der Urotoxizität von Oxazaphosphorinen

Packaging details

Description (FR)
UROMITEXAN sol inj 400 mg/4ml 15 amp 4 ml
Description (DE)
UROMITEXAN Inj Lös 400 mg/4ml 15 Amp 4 ml
Market launch
31/03/1981
Narcotic (BTM)
No